BETA

IPO registrations (S-1, F-1) · Registrants

Cardiovascular Systems Inc

SEC CIK
1180145 · filings on EDGAR ↗
Name on the registration
REPLIDYNE INC
Former names
REPLIDYNE INC (2002–2009)
Registration
Form S-1, first filed 2006-04-05, last 2006-06-28; 1 initial registration, 4 amendments
Outcome
Final prospectus filed 2006-06-28; declared effective 2006-06-28
Industry (SIC)
Surgical & Medical Instruments & Apparatus 3841
Incorporated in
DE
Business address
1225 OLD HWY 8 NW, St. Paul, MN 55112
EIN
41-1698056
EDGAR entity type
operating
Insiders and CEO pay
Cardiovascular Systems Inc on the corporate pages

Offering terms

Final price
$10.00 per share (424B4 filed 2006-06-28, an initial public offering)
Shares sold
4,500,000
Gross proceeds
$45,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol RDYN
Lead underwriters
Merrill Lynch
Syndicate
Morgan Stanley (1,755,000); Cowen (495,000); Pacific Growth Equities, LLC (495,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 8

FiledFormWhat it isName as filedEDGAR
2006-04-05S-1S-1 (registration)REPLIDYNE INC0001035704-06-000247 ↗
2006-05-22S-1/AS-1/A (amendment)REPLIDYNE INC0000950134-06-010386 ↗
2006-06-13S-1/AS-1/A (amendment)REPLIDYNE INC0000950134-06-011481 ↗
2006-06-26S-1/AS-1/A (amendment)REPLIDYNE INC0001035704-06-000459 ↗
2006-06-28S-1/AS-1/A (amendment)REPLIDYNE INC0000950134-06-012250 ↗
2006-06-28424B4424B4 (final prospectus)REPLIDYNE INC0000950134-06-012284 ↗
2006-06-28EFFECTEFFECT (declared effective)REPLIDYNE INC9999999995-06-000520 ↗
2006-10-12EFFECTEFFECT (declared effective)REPLIDYNE INC9999999995-06-001857 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2006-06-28S-1/Aregistration statement$10.004,500,000$45,000,000Nasdaq RDYN4primary document; price sentence, shares headline, proceeds computed, cover names 4document ↗
2006-06-28424B4final prospectus$10.004,500,000$45,000,000Nasdaq RDYN4primary document; price sentence, shares headline, proceeds table, underwriting table 3, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
AGUIAR ERICTenPercentOwner32006
CALHOUN KIRK KDirector32006–2008
CAVANAUGH JAMES HTenPercentOwner32006
Christoffersen Ralph EDirector32006
Collins Kenneth JDirector,OfficerPresident and CEO32006–2008
CROUSE WILLIAM WTenPercentOwner32006person page Fuzzy
DUYK GEOFFREY MDirector; Other42006–2009
EARL CHRISTOPHERDirector32006–2007
Echols RogerOfficerChief Medical Officer112006–2007
HEALTHCARE PARTNERS VI LPTenPercentOwner32006
HEALTHCARE VENTURES VI LPTenPercentOwner32006
Janjic NebojsaOfficerChief Scientific Officer, Sec.32006–2008
LAWLOR AUGUSTINEDirector; Director,TenPercentOwner272006–2023
Letendre PeterOfficerChief Commercial Officer42006–2007
LITTLECHILD JOHN WTenPercentOwner32006
Mirabelli ChristopherTenPercentOwner32006
MITCHELL DANIEL JDirector182006–2008
MORGENTHALER PARTNERS VII LPTenPercentOwner22006
Morrissey Donald J JrOfficerSr. VP, Corporate Development72006–2008
SMITH MARK LOfficerCFO and Treasurer32006–2008
Tarrant Advisors, IncOther; TenPercentOwner32006–2009
WENDT HENRYDirector42006–2007
WERNER HAROLD RTenPercentOwner32006
Brown Edward MDirector342007–2021
Betterley Laurence LOfficerChief Financial Officer472009–2017
Blackey Brent GDirector292009–2019
Doughty BrianOfficerVP of Commerical Operations; VP of Marketing102009–2011
Flaherty James EOfficerChief Administrative Officer342009–2014
FRIEDMAN JOHN HDirector242009–2013
Hartzler Geoffrey ODirector62009–2011
Howe Roger JDirector72009–2010
Koehn Paul AOfficerSVP Manufacturing & Operations; SVP Quality & Operations; VP of Manufacturing; VP Quality & Operations532009–2017
Martin DavidDirector,OfficerPresident and CEO542009–2015
NELSON GLEN DDirector292009–2014
Petrucci Gary MDirector52009–2010person page Fuzzy
Thatcher Robert JOfficerChief Healthcare Policy Off'r; Executive VP422009–2015
Tyska Paul AOfficerVP of Business Dev; VP of Business Dev.82009–2010
AINSLIE LEE S IIITenPercentOwner32009–2010
BONDERMAN DAVIDOther12009
COULTER JAMES GOther12009
MAVERICK CAPITAL LTDTenPercentOwner32009–2010
MAVERICK CAPITAL MANAGEMENT LLCTenPercentOwner32009–2010
Kraus Scott WilliamOfficerVP Sales162009–2011
Trigg LeslieDirector142011–2016
Kenny Kevin JOfficerChief Operating Officer; Exec. VP, Sales & Mtkg482011–2017
Discovery Group I, LLCTenPercentOwner102011–2012
Donoghue Daniel JTenPercentOwner102011–2012
Murphy Michael RTenPercentOwner102011–2012
Bartos Scott ADirector92012–2018
Ward Scott R.Director; Director,OfficerCEO and President; Chairman and CEO; Interim CEO and President352013–2023
Cohn William E.Director112015–2023
Camber Capital Management LLCTenPercentOwner42016
GILLUND LAURAOfficerChief Talent Officer92016–2018
Rosenstein AlexanderOfficerGeneral Counsel & Corp. Sec.; General Counsel & Corp. Secy322016–2023
Aronson Martha GoldbergDirector142017–2023
Sedo SandraOfficerChief Compliance Officer282017–2023
Robb Rhonda J.OfficerChief Operating Officer182018–2022
Points Jeffrey S.OfficerChief Financial Officer302018–2023
Egeland RyanOfficerChief Medical Officer; VP of Medical Affairs122019–2022
Hastings John M.OfficerVP Manufacturing & Operations142019–2022
Paulsen ErikDirector82019–2023
Whitescarver DavidOfficerVP of Corp. Dev. and IP; VP of Corp. Dev. & IP132019–2022
Stenbeck StephenDirector62019–2023
Rempe Stephen J.OfficerChief Human Resources Officer132020–2023person page Fuzzy
Womack Kelvin K.Director52020–2023
Jain Sachin H.Director42021–2022

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationCARDIOVASCULAR SYSTEMS, INC.MNState business registriesname and state
ContractorCARDIOVASCULAR SYSTEMS INCMNNonprofit contractors (Form 990)name and state
Plan sponsorCARDIOVASCULAR SYSTEMS, INC.MNForm 5500 (employee benefit plans)name and state
Federal award recipientCARDIOVASCULAR SYSTEMS INCMNFederal spending (USAspending)name and state
Federal award recipientCARDIOVASCULAR SYSTEMS, INCMNFederal spending (USAspending)name and state
Paying companyCardiovascular Systems Inc.MNOpen Payments (drug and device company payments)name and state
Patent assigneeCardiovascular Systems, Inc.MNPatents (USPTO)name and state
SEC filerCardiovascular Systems IncSEC filers (EDGAR)CIK (EXACT)
Trademark ownerCardiovascular Systems, Inc.MNTrademarks (USPTO)name and state
Business registrationCARDIOVASCULAR SYSTEMS, INC.State business registriesEIN (EXACT, as the state registration reports it)
Form 5500 plan sponsorCARDIOVASCULAR SYSTEMS, INC.EIN (EXACT)
Person pageGary M PetrucciPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pageMr Stephen J RempePeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer)
Person pageWilliam W CrousePeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Surgical & Medical Instruments & Apparatus, MN first:

More with this interest.

In other datasets, the same topic (Technology) in MN:

Interests: Surgical & Medical Instruments & Apparatus · Technology